Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
US10351571B2 · kind B2 · utility
15Cited by
65References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2018 |
| Grant date | Jul 16, 2019 |
| Priority date | — |
| Expiry date | May 24, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula: where R1, R2, R3, R4, R5, R5′, R6, X1, X2, m, and n are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.